Igniting Scalable Manufacturing Success in
Allogeneic Cell Therapy

Uniting Innovators for Advancement and Collaboration

Closing notice: Allogeneic Cell Therapy Searchlight network

A chapter concludes in the journey of collaborative excellence

We're in the process of making some significant changes at Hanson Wade. As part of these changes, our Allogeneic Cell Therapy Searchlight network will be closing down.  

However, this isn't the end of the road! We are excited to direct you towards other valuable opportunities and resources that Hanson Wade offers. Our commitment to providing industry-leading conferences, data and information products continues, and we believe these will be of great interest and value to you. 

Related Products:

Hanson Wade specializes in scientific research across various drug modalities, key diseases, and R&D areas.

Browse our different products spanning 200+ conferences, networking groups, bespoke market research services, and databases. Discover how we can help inform your drug development decision-making to accelerate safer, more effective, and accessible drugs to patients in need.



Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.

Market Research

A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.